TY - JOUR AU - Soria, Francesco AU - Gontero, Paolo PY - 2018 TI - How to assess and improve health-related quality of life in bladder cancer patients JF - Translational Andrology and Urology; Vol 7, Supplement 1 (March 14, 2018): Translational Andrology and Urology 1 Y2 - 2018 KW - N2 - Bladder cancer (BCa) is the second most common genitourinary cancer in men and the most common in women. Every year, worldwide, more than 400,000 patients receive a BCa diagnosis and 145,000 succumb to it. Due to its high incidence and its relatively low mortality rates, especially regarding low-risk non-muscle invasive bladder cancers (NMIBC), its worldwide prevalence is estimated to reach the impressive quote of 2,677,500 patients (1). Moreover, with the aging of population, BCa will become even more frequent and develop in an even bigger public health burden (2). UR - https://tau.amegroups.org/article/view/18579